VIVID: Vectra InVolved Informed Decision Outcome Study
VIVID: Vectra InVolved Informed Decision Outcome Study is a clinical trial open to United Rheumatology Members. Beginning in April 2019, Myriad Autoimmune will begin enrolling UR member sites. The primary objective of this study is to compare the clinical response from baseline to 6 months among patients with RA receiving Vectra-guided care versus those receiving treatment as usual.
Below is a recording of the webinar discussing the study design, eligibility criteria and how United Rheumatology can help identify eligible patients.
If you have any questions, or wish to learn more about VIVID, please contact Debra Shultis at (631) 656-7199.